Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 127

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 127
---
 Age      Position(s)                                             
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────
  Philip A. Serlin, CPA, MBA               64      Chief Executive Officer                                 
  Mali Zeevi, CPA                          49      Chief Financial Officer                                 
  Ella Sorani, Ph. D.                      57      Chief Development Officer                               
  Aharon Schwartz, Ph. D. (1)              82      Chairman of the Board of Directors, Class III Director  
  Rami Dar, MBA (1)(2)(3)(4)               68      Class I Director                                        
  B. J. Bormann, Ph. D. (1)(3)             66      Class II Director                                       
  Raphael Hofstein, Ph. D. (1)(2)(3)       75      Class II Director                                       
  Avraham Molcho, M. D. (1)(2)(3)          67      Class I Director                                        
  Sandra Panem, Ph. D. (1)(4)              78      Class III Director                                      
  Shaoyu Yan, Ph. D.                       60      Class III Director                                      
  Gal Cohen (1)                            52      Class I Director                                        

  (1)      Independent director under applicable Nasdaq Capital Market, as affirmatively determined by our board of  
  (2)      A member of our audit committee.                                                                          
  (3)      A member of our compensation committee.                                                                   
  (4)      A member of our investment monitoring committee                                                           

Philip A. Serlin, CPA, MBA, has served as our Chief Executive Officer since October 2016. From May 2009 to October 2016, Mr. Serlin served as our Chief Financial
and Operating Officer. From January 2008 to August 2008, Mr. Serlin served as the Chief Financial Officer and Chief Operating Officer
of Kayote Networks Inc. From January 2006 to December 2007, Mr. Serlin served as the Chief Financial Officer of Tescom Software Systems
Testing Ltd., an IT services company publicly traded in both Tel Aviv and London. Mr. Serlin’s background also includes senior positions
at Chiaro Networks Ltd. and at Deloitte, where he was head of the SEC and U. S. Accounting Department at the National Office in Tel Aviv,
as well as seven years at the SEC at its Washington, D. C., headquarters.